Medacta Group S.A.
MEDGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,614 | $1,515 | $1,565 | $2,515 |
| - Cash | $32 | $21 | $32 | $20 |
| + Debt | $241 | $202 | $170 | $133 |
| Enterprise Value | $1,823 | $1,696 | $1,703 | $2,627 |
| Revenue | $591 | $511 | $437 | $363 |
| % Growth | 15.6% | 16.9% | 20.4% | – |
| Gross Profit | $399 | $348 | $305 | $261 |
| % Margin | 67.6% | 68.1% | 69.8% | 71.9% |
| EBITDA | $161 | $120 | $107 | $98 |
| % Margin | 27.2% | 23.4% | 24.5% | 26.9% |
| Net Income | $73 | $47 | $46 | $52 |
| % Margin | 12.3% | 9.3% | 10.6% | 14.2% |
| EPS Diluted | 3.65 | 2.37 | 2.31 | 2.58 |
| % Growth | 54% | 2.6% | -10.5% | – |
| Operating Cash Flow | $107 | $75 | $74 | $54 |
| Capital Expenditures | -$105 | -$82 | -$63 | -$46 |
| Free Cash Flow | $2 | -$7 | $10 | $8 |